{"id":45954,"title":"Joao Andrade, CEO of WideCells Group plc speaks to us about today’s corporate update","publisher":"Share Talk","author":"sharetalk","published":"2017-12-21T07:49:44+00:00","modified":"2019-01-27T19:21:00+00:00","canonical_url":"https://www.share-talk.com/joao-andrade-ceo-of-widecells-group-plc-speaks-to-us-about-todays-corporate-update/","markdown_url":"https://www.share-talk.com/joao-andrade-ceo-of-widecells-group-plc-speaks-to-us-about-todays-corporate-update.md","json_url":"https://www.share-talk.com/joao-andrade-ceo-of-widecells-group-plc-speaks-to-us-about-todays-corporate-update.json","category":"Podcasts","categories":["Podcasts"],"tags":["WDC, Healthcare, StemCells, Research"],"featured_image":"https://i0.wp.com/www.share-talk.com/wp-content/uploads/2023/11/Stencil-Google-Chrome-2023-04-19-at-2.47.43-PM.jpeg?fit=1231%2C615&quality=89&ssl=1","format":"news","language":"en-GB","content":"Joao Andrade, CEO of main market listed WideCells Group Plc, talks to us about their RNS update today highlighting board changes and the addition of a new institutional broker partner in WG Partners.\n\nHe also goes on to discuss why they have created a new Scientific Advisory Board made up of top medics from around the world.\n\n#WDC #Healthcare #StemCells #Research"}